A Phase 1, Open-Label, Dose Escalation Study of ADG116 in Patients with Advanced/Metastatic Solid Tumors
- Park, John (Primary Chief Investigator)
- Chapman, Nicola, (Clinical Trial Unit Staff)
- Sabanathan, Dhanusha, (Associate Investigator)
Project: Research